171 related articles for article (PubMed ID: 35487060)
1. CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.
Deng J; Zhang T; Liu F; Han Q; Li Q; Guo X; Ma Y; Li L; Shao G
Biochem Biophys Res Commun; 2022 Jun; 611():107-113. PubMed ID: 35487060
[TBL] [Abstract][Full Text] [Related]
2. CRL4-DCAF8L1 Regulates BRCA1 and BARD1 Protein Stability.
Liu F; Han Q; Zhang T; Chang F; Deng J; Huang X; Wang W; Xu Y; Li Q; Xu L; Zhang B; Li W; Li L; Su Y; Li Y; Shao G
Int J Biol Sci; 2022; 18(4):1434-1450. PubMed ID: 35280675
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.
Hu Q; Botuyan MV; Zhao D; Cui G; Mer E; Mer G
Nature; 2021 Aug; 596(7872):438-443. PubMed ID: 34321665
[TBL] [Abstract][Full Text] [Related]
4. BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination.
Becker JR; Clifford G; Bonnet C; Groth A; Wilson MD; Chapman JR
Nature; 2021 Aug; 596(7872):433-437. PubMed ID: 34321663
[TBL] [Abstract][Full Text] [Related]
5. BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis.
Salas-Lloret D; García-Rodríguez N; Soto-Hidalgo E; González-Vinceiro L; Espejo-Serrano C; Giebel L; Mateos-Martín ML; de Ru AH; van Veelen PA; Huertas P; Vertegaal ACO; González-Prieto R
Nat Commun; 2024 May; 15(1):4292. PubMed ID: 38769345
[TBL] [Abstract][Full Text] [Related]
6. RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
Zhu Q; Huang J; Huang H; Li H; Yi P; Kloeber JA; Yuan J; Chen Y; Deng M; Luo K; Gao M; Guo G; Tu X; Yin P; Zhang Y; Su J; Chen J; Lou Z
Nat Commun; 2021 Nov; 12(1):6653. PubMed ID: 34789768
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
Dizin E; Irminger-Finger I
Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
[TBL] [Abstract][Full Text] [Related]
8. Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair.
Wang M; Li W; Tomimatsu N; Yu CH; Ji JH; Alejo S; Witus SR; Alimbetov D; Fitzgerald O; Wu B; Wang Q; Huang Y; Gan Y; Dong F; Kwon Y; Sareddy GR; Curiel TJ; Habib AA; Hromas R; Dos Santos Passos C; Yao T; Ivanov DN; Brzovic PS; Burma S; Klevit RE; Zhao W
Mol Cell; 2023 Oct; 83(20):3679-3691.e8. PubMed ID: 37797621
[TBL] [Abstract][Full Text] [Related]
9. HERC2 is an E3 ligase that targets BRCA1 for degradation.
Wu W; Sato K; Koike A; Nishikawa H; Koizumi H; Venkitaraman AR; Ohta T
Cancer Res; 2010 Aug; 70(15):6384-92. PubMed ID: 20631078
[TBL] [Abstract][Full Text] [Related]
10. SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.
Minten EV; Kapoor-Vazirani P; Li C; Zhang H; Balakrishnan K; Yu DS
Cell Rep; 2021 Mar; 34(13):108921. PubMed ID: 33789098
[TBL] [Abstract][Full Text] [Related]
11. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
12. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
13. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor ligands suppress ubiquitination and degradation of LXRalpha by displacing BARD1/BRCA1.
Kim KH; Yoon JM; Choi AH; Kim WS; Lee GY; Kim JB
Mol Endocrinol; 2009 Apr; 23(4):466-74. PubMed ID: 19164445
[TBL] [Abstract][Full Text] [Related]
15. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
[TBL] [Abstract][Full Text] [Related]
16. BRCA1/BARD1 is a nucleosome reader and writer.
Witus SR; Zhao W; Brzovic PS; Klevit RE
Trends Biochem Sci; 2022 Jul; 47(7):582-595. PubMed ID: 35351360
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
18. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
[TBL] [Abstract][Full Text] [Related]
19. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.
Reid LJ; Shakya R; Modi AP; Lokshin M; Cheng JT; Jasin M; Baer R; Ludwig T
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20876-81. PubMed ID: 19088202
[TBL] [Abstract][Full Text] [Related]
20. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
